Carrying one or two reduced-function CYP2C19 alleles is associated with an increased risk of major adverse cardiovascular events in people undergoing percutaneous coronary intervention and treated with clopidogrel

Evid Based Med. 2011 Aug;16(4):124-5. doi: 10.1136/ebm1203. Epub 2011 Jun 24.
No abstract available

Publication types

  • Comment
  • Research Support, N.I.H., Extramural
  • Research Support, Non-U.S. Gov't